Innovation Pharma announced the next phase of Brilacidin Coronavirus testing begun
On May 5, 2020, Innovation Pharma reported it had executed executed a Material Transfer Agreement (MTA) with a…
-
-
Vir and Alnylam identified RNAi therapeutic development candidate, VIR-2703 (ALN-COV), targeting SARS-CoV-2 for treatment of COVID-19
On May 4, 2020, Vir Biotech and Alnylam Pharma announced the selection of a development candidate for VIR-2703,…
-
US Dept of Veterans Affairs participated in drug, plasma trials in fight against COVID-19
On May 1, 2020, the U.S. Dept. of Veterans Affairs (VA) announced participation in a series of clinical…
-
Moderna and Lonza announced worldwide strategic collaboration to manufacture Moderna’s Vaccine (mRNA-1273) against novel Coronavirus
On May 1, 2020, Moderna and Lonza announced a 10-year strategic collaboration agreement to enable larger scale manufacture…
-
Texas A&M researchers lead testing of tuberculosis vaccine to fight COVID-19
On Apr. 29, 2020, a team of Texas A&M University researchers asked hundreds of frontline medical workers to…
-
Agriculture | Biotechnology | CRISPR | EPA | FDA | Genomics | USDA
Yield10 Bioscience obtains positive response from USDA-APHIS on regulatory status of CRISPR genome-edited C3007 trait in camelina
On Apr. 27, 2020, Yield10 Bioscience announced that it has obtained a positive response from USDA-APHIS’s Biotechnology Regulatory Services…
-
Moderna announced IND Submitted to FDA for phase 2 study of mRNA vaccine (mRNA-1273) against novel Coronavirus
On Apr. 27, 2020, Moderna announced it had submitted an Investigational New Drug application to the U.S. Food…
-
Researchers identified cells likely targeted by COVID-19 virus
On Apr. 22, 2020, researchers at Massachusetts Institute of Technology (MIT); the Ragon Institute of MGH, and Harvard…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
Biogen, Broad Institute of MIT and Harvard, Partners HealthCare launched consortium to build and share a COVID-19 Biobank
On Apr. 16, 2020, Biogen, Broad Institute of MIT and Harvard, and Partners HealthCare announced a consortium that…
-
Pulmatrix and Sensory Cloud announced partnership to develop and commercialize nasal prophylactic and anticontagion product for COVID-19
On Apr. 16, 2020, Pulmatrix announced a collaboration and license agreement with Sensory Cloud. Under the terms of…
-
Moderna announced BARDA award for up to $483 million to accelerate development of mRNA vaccine (mRNA-1273) against novel Coronavirus
On Apr. 16, 2020, the U.S. government announced it will fund development of an experimental coronavirus vaccine from…
-
Biogen, Broad Institute of MIT and Harvard, Partners HealthCare consortium build and share COVID-19 biobank
On Apr. 16, 2020, Biogen, Broad Institute of MIT and Harvard, and Partners HealthCare announced a consortium that will…
-
New antiviral drug from Emory University heading into clinical trials for COVID-19 treatment
On Apr. 6, 2020, Emory’s Vaccine and Treatment Evaluation Unit (VTEU) announced its participation in a clinical trial…
-
COVID-19 Therapeutics Accelerator awarded $20 million in initial grants to fund clinical trials
On Mar. 30, 2020, the partners in the COVID-19 Therapeutics Accelerator announced grants of $20 million to three…
-
Thermo Fisher Scientific received CE Mark for its Diagnostic test to Detect COVID-19
On Mar. 26, 2020, Thermo Fisher Scientific announced it had received the CE mark in the European Union…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Medical Device | Non-Profit Research | Therapeutics
Broad Institute’s CLIA-certified testing center began processing COVID-19 patient samples
On Mar. 26, 2020, working in partnership with the Commonwealth of Massachusetts, Massachusetts State Public Health Laboratory, and…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
Oxford University COVID-19 study showed that Wuhan travel restrictions prevented wider disease spread
On Mar. 25, 2020, a mobility and epidemiological study from a global consortium of researchers, led by the…
-
FDA provided Emergency Use Authorization to PerkinElmer for COVID-19 testing
On Mar. 24, 2020, PerkinElmer announced the U.S. Food and Drug Administration (FDA) had provided Emergency Use Authorization…
-
Biotechnology | Diagnostics | Medicine | NIH | Non-Profit Research | Oncology | Pharmaceutical | Radiology | Therapeutics
The Simmons Cancer Center joined elite National Comprehensive Cancer Network
On Mar. 24, 2020, the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern announced it had joined…
-
Harvard Bioscience introduced next generation inhalation system to aid in fight against COVID-19
On Mar. 23, 2020, Harvard Bioscience announced that it had launched an innovative technology – known as Accumulated…
-
Innovation Pharmaceuticals Brilacidin tested as drug and vaccine at different institutions
On Mar. 17, 2020, Innovation Pharma announced details on the Material Transfer Agreement signed with a leading public…
-
NIH clinical trial of investigational vaccine for COVID-19 began in Seattle
On Mar. 16, 2020, the National Institutes of Health (NIH announced that a Phase 1 clinical trial evaluating…
-
Moderna announced first participant dosed in NIH-led phase 1 study of mRNA vaccine against novel Coronavirus
On Mar. 16, 2020, Moderna announced that the first participant had been dosed in the Phase 1 study…
-
Biotechnology | COVID-19 | Diagnostics | FDA | Infectious Disease | Vaccine
Hologic’s molecular test for the novel Coronavirus, SARS-CoV-2, receives FDA Emergency Use Authorization
On Mar. 16, 2020, Hologic announced the U.S. Food and Drug Administration (FDA) had granted Emergency Use Authorization…
-
Sanofi and Regeneron began global Kevzara (sarilumab) clinical trial program in patients with severe COVID-19
On Mar. 16, 2020, Sanofi and Regeneron Pharma announced they have started a clinical program evaluating Kevzara (sarilumab)…
-
Enanta Pharmaceuticals announced efforts to discover treatment for novel Coronavirus disease
On Mar. 13, 2020, Enanta Pharmaceuticals announced it had initiated a program to discover direct-acting antiviral drug candidates…
-
U.S. Regional Biocontainment Lab to begin testing of Brilacidin against Coronavirus (COVID-19)
On Mar. 10, 2020, Innovation Pharma announced that management was advised that testing of Brilacidin, the Company’s flagship…
-
Moderna completed enrollment of Cytomegalovirus vaccine (mRNA-1647) phase 2 study
On Mar. 3, 2020, Moderna announced that enrollment was complete for all three dose cohorts of the Phase…
-
Innovation Pharma provided scientific rationale and clinical development perspectives for Brilacidin as potential Coronavirus treatment
On Mar. 2, 2020, Innovation Pharma provided the scientific rationale and clinical development perspectives for Brilacidin, the Company’s…
-
Biotechnology | COVID-19 | Diagnostics | Life Science History | Non-Profit Research | Therapeutics | Vaccine
Boston University NEIDL scientists joined international Coronavirus research effort
On Mar. 2, 2020, Boston’s top infectious disease researchers, including scientists from Boston University’s National Emerging Infectious Diseases…
